Structure Therapeutics Inc. Sponsored ADR GPCR

35.93 (0.09) (0.25%) as of 25 Sep
Market cap
$2.6B
P/E
0.0×
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Current Ratio

+8 more quarters

14.15 24.81 26.16 20.75
Net Debt/EBITDA
10.41 (38.49) 15.84 11.05
Debt/Assets
0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00
Asset Turnover
0.00 0.00 0.00 0.00
Operating CF/Net income
0.78 (1.95) (0.20) 1.13
Capex/Depreciation
0.54 (0.11) 0.44 (0.01)
Interest Coverage
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00%
Free Cash Flow per Share
(0.90) (1.11) 0.19 (1.65)
Cash per Share
13.66 24.43 20.13 18.48
Shareholders Equity per Share
13.17 25.61 19.98 18.64
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
13.17 25.61 19.98 18.64
Free Cash Flow
(52.57) (65.91) 14.05 (120.07)
Working Capital
756.50 1,507.02 1,433.61 1,305.92
Capital Expenditures
(1.57) (1.50) (1.18) 0.04
Net Current Asset Value
751.88 1,502.76 1,429.57 1,301.02
Other line items
Quick Ratio
13.89 24.43 25.60 20.31
Revenue per Share
0.00 0.00 0.00 0.00
Operating CF per Share
(0.87) (1.09) 0.21 (1.65)
Capex per Share
(0.03) (0.03) (0.02) 0.00
Average Payables
13.12 10.94 8.27 10.06
Average Assets
882.69 1,243.62 1,187.34 1,120.93
Average Common Equity
833.41 1,190.61 1,135.87 1,063.24
Capex to Sales
0.00 0.00 0.00 0.00
Net Profit Margin
0.00% 0.00% 0.00% 0.00%

Fold the line items

Columns are period end dates